Accuray (ARAY) Non Operating Interest Expenses (2024 - 2025)
Accuray's (ARAY) quarterly Non Operating Interest Expenses came in at $284000.0 in Q3 2025, up 273.68% year-on-year from $76000.0 in Q3 2024, and up 273.68% quarter-over-quarter from $76000.0 in Q3 2024.
Accuray (ARAY) Non Operating Interest Expenses (2024 - 2025) Analysis & Trends
Accuray's Non Operating Interest Expenses history runs 2 years deep, the most recent figure standing at $284000.0 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Accuray | 29,832.96 | -38.50 Mn | 25.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 284,000.00 |
| Sep 30, 2024 | 76,000.00 |